12 results on '"Kukreti V"'
Search Results
2. CyBorD induction therapy in clinical practice
3. Early relapse after single auto-SCT for multiple myeloma is a major predictor of survival in the era of novel agents
4. Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure
5. Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study
6. A phase II study (PX-171–003-A1) of single-agent carfilzomib in patients with advanced relapsed and refractory multiple myeloma (RRMM): 14
7. Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial
8. Phase II Study of Carfilzomib (CFZ) in Patients with Relapsed Myeloma (MM) (PX-171-004): A493
9. Retropective Comparison of Engraftment After First and Second Autotransplantations for Relapsed Myeloma: A458
10. Phase II Study of Carfilzomib in Patients with Relapsed Myeloma (PX-171-004): A378
11. Phase I/II Trial of Cyclophosphamide, Prednisone, and Lenalidomide for Relapsed and Refractory MM: A333
12. Bortezomib-Based Therapy Following Prior Lenalidomide + Dexamethasone in Relapsed Multiple Myeloma: A334
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.